MarketPeel
Chief Legal Officer & Corp Sec
Wed, Jan 28, 2026
Jan 28
exercised or converted securities in ABOS
2,671 shares @ $0.00
Decreased holdings by -3.10%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
ABOSAcumen Pharmaceuticals, Inc.
Health CareBiotechnology
1D0.00%
1W+18.80%
1M+48.36%
3M+30.58%
6M
1Y

Recent insider activity at ABOS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback